say the anchor of helping figuring out what the path forward was going to be was when we hired cathy hibbsf genomic health. she had a tremendous amount of experience with genomic health. she understood genetics. she understood fda and added an element of structure to the company so that people could see that path that we were taking and that people wanted to join on. emily: there is so much more you want to accomplish. like the test for breast cancer and alzheimer's, those have not been approved. what's the progress on that? anne: it's top my priority list. i think customers really want breast cancer results. they really want the alzheimer's test. those are the types of things we're talking to the fda about. what is that path going to look like to move that forward. i don't have any updates yet on that. emily: your original idea was to give customers access to their own data and to amass so much data you could singlehanded move science forward. you say you now have one million customers. is this the single biggest dna database out there? anne: it's definitely the biggest one being used for